Fibernorm Interactions
There are 33 drugs known to interact with Fibernorm (polycarbophil), along with 5 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 7 are moderate, and 26 are minor.
- View all 33 medications that may interact with Fibernorm
- View Fibernorm alcohol/food interactions (1)
- View Fibernorm disease interactions (5)
Most frequently checked interactions
View interaction reports for Fibernorm (polycarbophil) and the medicines listed below.
- Actos (pioglitazone)
- Aldactone (spironolactone)
- allopurinol
- alprazolam
- bacitracin
- baclofen
- caffeine
- Centrum Adults (multivitamin with minerals)
- Centrum Silver Men's (multivitamin with minerals)
- chromic chloride hexahydrate / copper sulfate / manganese sulfate / selenium / zinc sulfate
- Cialis (tadalafil)
- citicoline
- Clindamax (clindamycin topical)
- clonazepam
- Concerta (methylphenidate)
- Copper (copper gluconate)
- diazepam
- dimenhydrinate
- Dramamine (dimenhydrinate)
- esomeprazole
- fluoxetine
- flurazepam
- magnesium amino acids chelate
- melatonin
- metformin
- metoclopramide
- ondansetron
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- vitamin e
Fibernorm alcohol/food interactions
There is 1 alcohol/food interaction with Fibernorm (polycarbophil).
Fibernorm disease interactions
There are 5 disease interactions with Fibernorm (polycarbophil) which include:
- intestinal obstruction
- inflammatory bowel disease
- intestinal obstruction disorders
- renal dysfunction
- hypercalcemia
Report options
QR code containing a link to this page
More about Fibernorm (polycarbophil)
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.